Low human papillomavirus prevalence in head and neck cancer: results from two large case–control studies in high-incidence regions

HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women

(2010) Maura L. Gillison et al.   CANCER

TP53 and EGFR mutations in combination with lifestyle risk factors in tumours of the upper aerodigestive tract from South America

(2009) K. Szymańska et al.   CARCINOGENESIS

Recent changes in the epidemiology of head and neck cancer

(2009) Maria Paula Curado et al.   CURRENT OPINION IN ONCOLOGY

Oral Sexual Behaviors Associated with Prevalent Oral Human Papillomavirus Infection

(2009) Gypsyamber D’Souza et al.   JOURNAL OF INFECTIOUS DISEASES

Demographic and risk factors in patients with head and neck tumors

(2009) Ruth Tachezy et al.   JOURNAL OF MEDICAL VIROLOGY

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY

Does Pretreatment Seropositivity to Human Papillomavirus Have Prognostic Significance for Head and Neck Cancers?

(2008) E. M. Smith et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States

(2008) Anil K. Chaturvedi et al.   JOURNAL OF CLINICAL ONCOLOGY

Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers

(2008) Maura L. Gillison et al.   JNCI-Journal of the National Cancer Institute

Seroprevalence of 34 Human Papillomavirus Types in the German General Population

(2008) Kristina M. Michael et al.   PLoS Pathogens

Human papillomavirus infection and oral cancer: A case-control study in Montreal, Canada

(2007) Javier Pintos et al.   ORAL ONCOLOGY